Financhill
Back

Intellia Therapeutics Vs. Merchants Bancorp Industry Stock Comparison

Sell
16

NTLA
Intellia Therapeutics

Last Price:
14.31
Seasonality Move:
11.52%
Sell
27

MBIN
Merchants Bancorp

Last Price:
36.00
Seasonality Move:
17.97%
Sell
16
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $14.99. The Score for NTLA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
27
Merchants Bancorp (MBIN) is a Sell

Is Merchants Bancorp a Buy, Sell or Hold?

  • The current Merchants Bancorp [MBIN] share price is $36.03. The Score for MBIN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • MBIN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $14.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.

MBIN Stock Price Chart

What is Merchants Bancorp's stock price today?

  • The Merchants Bancorp share price today is $36.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MBIN is experiencing selling pressure, which indicates risk of future bearish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.07 Sell
Relative Strength Index (14 RSI): 29.39 Sell
Chaikin Money Flow: -2709398 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.08 - 20.76) Sell
Bollinger Bands (100): (19.61 - 24.99) Sell

MBIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.76 Sell
Relative Strength Index (14 RSI): 25.42 Sell
Chaikin Money Flow: -628222 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.21 - 45.71) Sell
Bollinger Bands (100): (40.42 - 46.66) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.24 Sell
20-day SMA: 18.44 Sell
50-day SMA: 20.47 Sell
200-day SMA: 24.02 Sell
8-day EMA: 17.31 Sell
20-day EMA: 18.56 Sell
50-day EMA: 20.12 Sell
200-day EMA: 24.39 Sell

MBIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43 Sell
20-day SMA: 43.81 Sell
50-day SMA: 44.3 Sell
200-day SMA: 42.61 Sell
8-day EMA: 42.26 Sell
20-day EMA: 43.47 Sell
50-day EMA: 43.87 Sell
200-day EMA: 41.55 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.19 per share.

Merchants Bancorp Earnings Growth & MBIN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and a decrease next year of $0.25 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Merchants Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):